These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6145185)

  • 1. Behavioural pharmacology of benzodiazepines.
    File SE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):19-31. PubMed ID: 6145185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance.
    File SE
    Psychopharmacology (Berl); 1982; 77(3):284-8. PubMed ID: 6126909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats.
    File SE
    Psychopharmacology (Berl); 1981; 73(3):240-5. PubMed ID: 6113617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam.
    Fernandes C; Arnot MI; Irvine EE; Bateson AN; Martin IL; File SE
    Psychopharmacology (Berl); 1999 Aug; 145(3):251-9. PubMed ID: 10494573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional tolerance to lorazepam in the rat.
    Lister RG; File SE; Greenblatt DJ
    Psychopharmacology (Berl); 1983; 81(4):292-4. PubMed ID: 6419257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of differential tolerance to the sedative and anti-stress effects of benzodiazepines.
    Mediratta PK; Sharma KK; Rana J
    Indian J Physiol Pharmacol; 2001 Jan; 45(1):111-5. PubMed ID: 11211563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of repeated-trial tolerance to the anxiolytic-like effects of chlordiazepoxide in the rat triple test.
    Wehrmeister TD; Izídio GS; Pereira E; Izídio G; Ramos A
    Pharmacol Biochem Behav; 2010 Dec; 97(2):301-9. PubMed ID: 20817009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sedative effects of PK 9084 and PK 8165, alone and in combination with chlordiazepoxide.
    File SE
    Br J Pharmacol; 1983 May; 79(1):219-23. PubMed ID: 6871544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioural effects of lorazepam are poorly related to its concentration in the brain.
    Lister RG; File SE; Greenblatt DJ
    Life Sci; 1983 Apr; 32(17):2033-40. PubMed ID: 6132319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
    Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
    Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard.
    File SE; Pellow S
    Br J Pharmacol; 1985 Nov; 86(3):729-35. PubMed ID: 2866006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sedative effects of CL 218,872, like those of chlordiazepoxide, are reversed by benzodiazepine antagonists.
    File SE; Pellow S; Wilks L
    Psychopharmacology (Berl); 1985; 85(3):295-300. PubMed ID: 2860685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the development of tolerance to various benzodiazepines.
    Nowakowska E; Chodera A; Cenajek-Musiał D; Szczawińska K
    Pol J Pharmacol Pharm; 1987; 39(3):245-52. PubMed ID: 2894019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic bretazenil produces tolerance to chlordiazepoxide, midazolam, and abecarnil.
    Bronson ME
    Pharmacol Biochem Behav; 1995; 51(2-3):481-90. PubMed ID: 7667373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid tolerance and crosstolerance to motor impairment effects of benzodiazepines, barbiturates, and ethanol.
    Khanna JM; Kalant H; Chau A; Shah G
    Pharmacol Biochem Behav; 1998 Feb; 59(2):511-9. PubMed ID: 9477002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of acute and chronic triazolam treatments in albino rats.
    Aburawi SM; Elhwuegi AS; Ahmed SS; Saad SF; Attia AS
    Life Sci; 2003 Oct; 73(24):3095-107. PubMed ID: 14550850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to a new class of non-benzodiazepine anxiolytics.
    Chodera A; Nowakowska E; Bartczak G
    Pol J Pharmacol; 1994; 46(5):479-81. PubMed ID: 7894538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons.
    Griffiths RR; Lamb RJ; Sannerud CA; Ator NA; Brady JV
    Psychopharmacology (Berl); 1991; 103(2):154-61. PubMed ID: 1674158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.